Nucleic Acids Research, Vol 27, Issue 22 4328-4334, Copyright © 1999 by Oxford University Press
V Patzel, U Steidl, R Kronenwett, R Haas and G Sczakiel
Up to now, out of approximately 20 antisense oligodeoxyribonucleotides (as
ODN) selected and tested against a given target gene, only one species
shows substantial suppression of target gene expression. In part, this
seems to be related to the general assumption that the structures of local
target sequences or antisense nucleic acids are unfavorable for efficient
annealing. Experimental approaches to find effective as ODN are extremely
expensive when including a large number of antisense species and when
considering their moderate success. Here, we make use of a systematic
alignment of computer-predicted secondary structures of local sequence
stretches of the target RNA and of semi- empirical rules to identify
favorable local target sequences and, hence, to design more effective as
ODN. The intercellular adhesion molecule 1 (ICAM-1) gene was chosen as a
target because it had been shown earlier to be sensitive to
antisense-mediated gene suppression. By applying the protocol described
here, 10 ICAM-1-directed as ODN species were found that showed
substantially improved inhibition of target gene expression in the
endothelial cell line ECV304 when compared with the most effective
published as ODN. Further, 17 out of 34 antisense species (50%) selected on
the theoretical basis described here showed significant (>50%)
inhibition of ICAM-1 expression in mammalian cells.
ARTICLES
A theoretical approach to select effective antisense oligodeoxyribonucleotides at high statistical probability
Forschungsschwerpunkt Angewandte Tumorvirologie, Deutsches Krebsforschungszentrum, Heidelberg, Germany.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
P. Luciani, C. Deledda, F. Rosati, S. Benvenuti, I. Cellai, F. Dichiara, M. Morello, G. B. Vannelli, G. Danza, M. Serio, et al. Seladin-1 Is a Fundamental Mediator of the Neuroprotective Effects of Estrogen in Human Neuroblast Long-Term Cell Cultures Endocrinology, September 1, 2008; 149(9): 4256 - 4266. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shao, Y. Wu, C. Y. Chan, K. McDonough, and Y. Ding Rational design and rapid screening of antisense oligonucleotides for prokaryotic gene modulation Nucleic Acids Res., November 14, 2006; 34(19): 5660 - 5669. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Jakobsen, C. K. Damgaard, E. S. Andersen, A. Podhajska, and J. Kjems A genomic selection strategy to identify accessible and dimerization blocking targets in the 5'-UTR of HIV-1 RNA Nucleic Acids Res., April 23, 2004; 32(7): e67 - e67. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. V. Matveeva, D. H. Mathews, A. D. Tsodikov, S. A. Shabalina, R. F. Gesteland, J. F. Atkins, and S. M. Freier Thermodynamic criteria for high hit rate antisense oligonucleotide design Nucleic Acids Res., September 1, 2003; 31(17): 4989 - 4994. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Husken, F. Asselbergs, B. Kinzel, F. Natt, J. Weiler, P. Martin, R. Haner, and J. Hall mRNA fusion constructs serve in a general cell-based assay to profile oligonucleotide activity Nucleic Acids Res., September 1, 2003; 31(17): e102 - e102. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kraemer, S. Fuessel, U. Schmidt, M. Kotzsch, B. Schwenzer, M. P. Wirth, and A. Meye Antisense-mediated hTERT Inhibition Specifically Reduces the Growth of Human Bladder Cancer Cells Clin. Cancer Res., September 1, 2003; 9(10): 3794 - 3800. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kretschmer-Kazemi Far and G. Sczakiel The activity of siRNA in mammalian cells is related to structural target accessibility: a comparison with antisense oligonucleotides Nucleic Acids Res., August 1, 2003; 31(15): 4417 - 4424. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-Y. Zhang, J. Mao, D. Zhou, Y. Xu, H. Thonberg, Z. Liang, and C. Wahlestedt mRNA accessible site tagging (MAST): a novel high throughput method for selecting effective antisense oligonucleotides Nucleic Acids Res., July 15, 2003; 31(14): e72 - e72. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Frendo, D. Olivier, V. Cheynet, J.-L. Blond, O. Bouton, M. Vidaud, M. Rabreau, D. Evain-Brion, and F. Mallet Direct Involvement of HERV-W Env Glycoprotein in Human Trophoblast Cell Fusion and Differentiation Mol. Cell. Biol., May 15, 2003; 23(10): 3566 - 3574. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ryu, J. Lee, B. A. Olofsson, A. Mwidau, A. Dedeoglu, M. Escudero, E. Flemington, J. Azizkhan-Clifford, R. J. Ferrante, and R. R. Ratan Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway PNAS, April 1, 2003; 100(7): 4281 - 4286. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Luebke, R. P. Balog, and H. R. Garner Prioritized selection of oligodeoxyribonucleotide probes for efficient hybridization to RNA transcripts Nucleic Acids Res., January 15, 2003; 31(2): 750 - 758. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Giddings, A. A. Shah, S. Freier, J. F. Atkins, R. F. Gesteland, and O. V. Matveeva Artificial neural network prediction of antisense oligodeoxynucleotide activity Nucleic Acids Res., October 1, 2002; 30(19): 4295 - 4304. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Dias and C. A. Stein Antisense Oligonucleotides: Basic Concepts and Mechanisms Mol. Cancer Ther., March 1, 2002; 1(5): 347 - 355. [Full Text] [PDF] |
||||
![]() |
B. H. Lloyd, R. V. Giles, D. G. Spiller, J. Grzybowski, D. M. Tidd, and D. R. Sibson Determination of optimal sites of antisense oligonucleotide cleavage within TNF{alpha} mRNA Nucleic Acids Res., September 1, 2001; 29(17): 3664 - 3673. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sohail, H. Hochegger, A. Klotzbucher, R. L. Guellec, T. Hunt, and E. M. Southern Antisense oligonucleotides selected by hybridisation to scanning arrays are effective reagents in vivo Nucleic Acids Res., May 15, 2001; 29(10): 2041 - 2051. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Bramlage, E. Luzi, and F. Eckstein HIV-1 LTR as a target for synthetic ribozyme-mediated inhibition of gene expression: site selection and inhibition in cell culture Nucleic Acids Res., November 1, 2000; 28(21): 4059 - 4067. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Amarzguioui, G. Brede, E. Babaie, M. Grotli, B. Sproat, and H. Prydz Secondary structure prediction and in vitro accessibility of mRNA as tools in the selection of target sites for ribozymes Nucleic Acids Res., November 1, 2000; 28(21): 4113 - 4124. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. V. Matveeva, A. D. Tsodikov, M. Giddings, S. M. Freier, J. R. Wyatt, A. N. Spiridonov, S. A. Shabalina, R. F. Gesteland, and J. F. Atkins Identification of sequence motifs in oligonucleotides whose presence is correlated with antisense activity Nucleic Acids Res., August 1, 2000; 28(15): 2862 - 2865. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Scherr, J. J. Rossi, G. Sczakiel, and V. Patzel RNA accessibility prediction: a theoretical approach is consistent with experimental studies in cell extracts Nucleic Acids Res., July 1, 2000; 28(13): 2455 - 2461. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Lehmann, V. Patzel, and G. Sczakiel Theoretical design of antisense genes with statistically increased efficacy Nucleic Acids Res., July 1, 2000; 28(13): 2597 - 2604. [Abstract] [Full Text] [PDF] |
||||





